Page 8 - Gene Therapy Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Passage Bio (NASDAQ:PASG – Get Free Report) and Immatics (NASDAQ:IMTX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability and earnings. Institutional and Insider Ownership 61.6% of Passage Bio […]

Dyadic International (NASDAQ:DYAI – Get Free Report) and Passage Bio (NASDAQ:PASG – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, earnings, profitability and analyst recommendations. Profitability This table compares Dyadic International and […]

5-Year-Old Hampton Boy First in Virginia to Receive Treatment...

/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...

Reported promising interim data from Cohorts 1-4 in the Imagine-1 clinical trial for GM1 gangliosidosis ; PBGM01 continued to have a favorable safety profile and dose-dependent effects on key CSF...